A citation-based method for searching scientific literature

Wenjuan Du, Erik de Vries, Frank J M van Kuppeveld, Mikhail Matrosovich, Cornelis A M de Haan. FEBS J 2021
Times Cited: 5







List of co-cited articles
33 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Kinetic analysis of the influenza A virus HA/NA balance reveals contribution of NA to virus-receptor binding and NA-dependent rolling on receptor-containing surfaces.
Hongbo Guo, Huib Rabouw, Anne Slomp, Meiling Dai, Floor van der Vegt, Jan W M van Lent, Ryan McBride, James C Paulson, Raoul J de Groot, Frank J M van Kuppeveld,[...]. PLoS Pathog 2018
54
80


Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase.
Miriam Cohen, Xing-Quan Zhang, Hooman P Senaati, Hui-Wen Chen, Nissi M Varki, Robert T Schooley, Pascal Gagneux. Virol J 2013
147
60

Influenza A Virus Hemagglutinin-Neuraminidase-Receptor Balance: Preserving Virus Motility.
Erik de Vries, Wenjuan Du, Hongbo Guo, Cornelis A M de Haan. Trends Microbiol 2020
34
60


N-Glycolylneuraminic Acid as a Receptor for Influenza A Viruses.
Frederik Broszeit, Netanel Tzarum, Xueyong Zhu, Nikoloz Nemanichvili, Dirk Eggink, Tim Leenders, Zeshi Li, Lin Liu, Margreet A Wolfert, Andreas Papanikolaou,[...]. Cell Rep 2019
36
40

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium.
Mikhail N Matrosovich, Tatyana Y Matrosovich, Thomas Gray, Noel A Roberts, Hans-Dieter Klenk. J Virol 2004
375
40

Influenza virus sialidase: effect of calcium on steady-state kinetic parameters.
A K Chong, M S Pegg, M von Itzstein. Biochim Biophys Acta 1991
59
40

Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies.
Xueyong Zhu, Hannah L Turner, Shanshan Lang, Ryan McBride, Sandhya Bangaru, Iuliia M Gilchuk, Wenli Yu, James C Paulson, James E Crowe, Andrew B Ward,[...]. Cell Host Microbe 2019
23
40

Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses.
Hongquan Wan, Jin Gao, Kemin Xu, Hongjun Chen, Laura K Couzens, Katie H Rivers, Judy D Easterbrook, Kevin Yang, Lei Zhong, Mohsen Rajabi,[...]. J Virol 2013
89
40

Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice.
Iuliia M Gilchuk, Sandhya Bangaru, Pavlo Gilchuk, Ryan P Irving, Nurgun Kose, Robin G Bombardi, Natalie J Thornburg, C Buddy Creech, Kathryn M Edwards, Sheng Li,[...]. Cell Host Microbe 2019
20
40

Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.
Hongquan Wan, Hua Yang, David A Shore, Rebecca J Garten, Laura Couzens, Jin Gao, Lianlian Jiang, Paul J Carney, Julie Villanueva, James Stevens,[...]. Nat Commun 2015
49
40

Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.
W R Tulip, J N Varghese, W G Laver, R G Webster, P M Colman. J Mol Biol 1992
199
40

Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies.
Michael Schotsaert, Tine Ysenbaert, Anouk Smet, Bert Schepens, Dieter Vanderschaeghe, Svetlana Stegalkina, Thorsten U Vogel, Nico Callewaert, Walter Fiers, Xavier Saelens. Sci Rep 2016
36
40

Influenza neuraminidase.
Gillian M Air. Influenza Other Respir Viruses 2012
139
40

Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.
Lianlian Jiang, Giovanna Fantoni, Laura Couzens, Jin Gao, Ewan Plant, Zhiping Ye, Maryna C Eichelberger, Hongquan Wan. J Virol 2015
31
40

Identification of Residues That Affect Oligomerization and/or Enzymatic Activity of Influenza Virus H5N1 Neuraminidase Proteins.
Meiling Dai, Hongbo Guo, Jos C F M Dortmans, Jojanneke Dekkers, Johan Nordholm, Robert Daniels, Frank J M van Kuppeveld, Erik de Vries, Cornelis A M de Haan. J Virol 2016
18
40


Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.
Pramila Rijal, Bei Bei Wang, Tiong Kit Tan, Lisa Schimanski, Philipp Janesch, Tao Dong, John W McCauley, Rodney S Daniels, Alain R Townsend, Kuan-Ying A Huang. J Virol 2020
12
40

Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
Jin Gao, Laura Couzens, David F Burke, Hongquan Wan, Patrick Wilson, Matthew J Memoli, Xiyan Xu, Ruth Harvey, Jens Wrammert, Rafi Ahmed,[...]. mBio 2019
24
40

Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus.
Atsuhiro Yasuhara, Seiya Yamayoshi, Maki Kiso, Yuko Sakai-Tagawa, Michiko Koga, Eisuke Adachi, Tadashi Kikuchi, I-Hsuan Wang, Shinya Yamada, Yoshihiro Kawaoka. Nat Microbiol 2019
14
40

Calcium is needed for the thermostability of influenza B virus neuraminidase.
W P Burmeister, S Cusack, R W Ruigrok. J Gen Virol 1994
39
40

Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
Arnold S Monto, Joshua G Petrie, Rachel T Cross, Emileigh Johnson, Merry Liu, Weimin Zhong, Min Levine, Jacqueline M Katz, Suzanne E Ohmit. J Infect Dis 2015
168
40


Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.
Francisco Miguel Cardoso, Lorena Itatí Ibañez, Silvie Van den Hoecke, Sarah De Baets, Anouk Smet, Kenny Roose, Bert Schepens, Francis J Descamps, Walter Fiers, Serge Muyldermans,[...]. J Virol 2014
35
40

Mapping the antigenic and genetic evolution of influenza virus.
Derek J Smith, Alan S Lapedes, Jan C de Jong, Theo M Bestebroer, Guus F Rimmelzwaan, Albert D M E Osterhaus, Ron A M Fouchier. Science 2004
40

Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
E R Job, M Schotsaert, L I Ibañez, A Smet, T Ysenbaert, K Roose, M Dai, C A M de Haan, H Kleanthous, T U Vogel,[...]. J Virol 2018
16
40

Structural characterization of the 1918 influenza virus H1N1 neuraminidase.
Xiaojin Xu, Xueyong Zhu, Raymond A Dwek, James Stevens, Ian A Wilson. J Virol 2008
176
40

Structural restrictions for influenza neuraminidase activity promote adaptation and diversification.
Hao Wang, Dan Dou, Henrik Östbye, Rebecca Revol, Robert Daniels. Nat Microbiol 2019
9
40

Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses.
Jennifer Uhlendorff, Tatyana Matrosovich, Hans-Dieter Klenk, Mikhail Matrosovich. Arch Virol 2009
69
40

The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance.
Wenjuan Du, Hongbo Guo, Vera S Nijman, Jennifer Doedt, Erhard van der Vries, Joline van der Lee, Zeshi Li, Geert-Jan Boons, Frank J M van Kuppeveld, Erik de Vries,[...]. PLoS Pathog 2019
19
40

Broadly protective human antibodies that target the active site of influenza virus neuraminidase.
Daniel Stadlbauer, Xueyong Zhu, Meagan McMahon, Jackson S Turner, Teddy J Wohlbold, Aaron J Schmitz, Shirin Strohmeier, Wenli Yu, Raffael Nachbagauer, Philip A Mudd,[...]. Science 2019
69
40

The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody.
R L Malby, W R Tulip, V R Harley, J L McKimm-Breschkin, W G Laver, R G Webster, P M Colman. Structure 1994
130
40

Nucleosides for the treatment of respiratory RNA virus infections.
Paul C Jordan, Sarah K Stevens, Jerome Deval. Antivir Chem Chemother 2018
60
20

Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice.
Natalia A Ilyushina, Alan Hay, Neziha Yilmaz, Adrianus C M Boon, Robert G Webster, Elena A Govorkova. Antimicrob Agents Chemother 2008
95
20

Antiviral treatment of severe non-influenza respiratory virus infection.
Nathan J Brendish, Tristan W Clark. Curr Opin Infect Dis 2017
15
20

Implications of segment mismatch for influenza A virus evolution.
Maria C White, Anice C Lowen. J Gen Virol 2018
31
20

V292I mutation in PB2 polymerase induces increased effects of E627K on influenza H7N9 virus replication in cells.
Yuqing Zhou, Xiaoxin Wu, Danying Yan, Can Chen, Xiaoxiao Liu, Chenyang Huang, Xiaofang Fu, Guo Tian, Cheng Ding, Jie Wu,[...]. Virus Res 2021
2
50

Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
Michael G Ison, Simon Portsmouth, Yuki Yoshida, Takao Shishido, Melissa Mitchener, Kenji Tsuchiya, Takeki Uehara, Frederick G Hayden. Lancet Infect Dis 2020
50
20

Recurring influenza B virus infections in seals.
Rogier Bodewes, Danny Morick, Gerrie de Mutsert, Nynke Osinga, Theo Bestebroer, Stefan van der Vliet, Saskia L Smits, Thijs Kuiken, Guus F Rimmelzwaan, Ron A M Fouchier,[...]. Emerg Infect Dis 2013
60
20

The role of fusion activity of influenza A viruses in their biological properties.
L Jakubcová, J Hollý, E Varečková. Acta Virol 2016
6
20


Identification of traditional medicinal plant extracts with novel anti-influenza activity.
Dhivya Rajasekaran, Enzo A Palombo, Tiong Chia Yeo, Diana Lim Siok Ley, Chu Lee Tu, Francois Malherbe, Lara Grollo. PLoS One 2013
38
20


Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.
Giuseppe Belardo, Orlando Cenciarelli, Simone La Frazia, Jean Francois Rossignol, M Gabriella Santoro. Antimicrob Agents Chemother 2015
55
20

Pharmacokinetic and pharmacodynamic analysis of baloxavir marboxil, a novel cap-dependent endonuclease inhibitor, in a murine model of influenza virus infection.
Yoshinori Ando, Takeshi Noshi, Kenji Sato, Toru Ishibashi, Yuki Yoshida, Takahiro Hasegawa, Motoyasu Onishi, Mitsutaka Kitano, Ryoko Oka, Makoto Kawai,[...]. J Antimicrob Chemother 2021
3
33

Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir1.
Vasiliy P Mishin, Mira C Patel, Anton Chesnokov, Juan De La Cruz, Ha T Nguyen, Lori Lollis, Erin Hodges, Yunho Jang, John Barnes, Timothy Uyeki,[...]. Emerg Infect Dis 2019
27
20

Influenza and other emerging respiratory viruses.
Maria Zambon. Medicine (Abingdon) 2014
6
20

The effects of the Xijiao Dihuang decoction combined with Yinqiao powder on miRNA-mRNA profiles in mice infected with influenza a virus.
Ke Li, Xiaoming Chen, Jing Zhong, Hehe Ye, Shujing Zhang, Dongyu Ge, Xudan Wang, Ying Wu. BMC Complement Med Ther 2020
3
33

Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway.
Wei Wang, Jiandong Wu, Xiaoshuang Zhang, Cui Hao, Xiaoliang Zhao, Guangling Jiao, Xindi Shan, Wenjing Tai, Guangli Yu. Sci Rep 2017
47
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.